Published in World J Psychiatry on March 22, 2016
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet (2008) 10.49
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci (2007) 7.54
The molecular neurobiology of depression. Nature (2008) 6.51
Psychological and neural mechanisms of the affective dimension of pain. Science (2000) 4.98
Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol (2007) 3.94
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull (2009) 3.82
Radial glial identity is promoted by Notch1 signaling in the murine forebrain. Neuron (2000) 3.70
The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell (2009) 3.60
Characterization of a rat model of incisional pain. Pain (1996) 3.55
Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci (2013) 3.53
Basic helix-loop-helix factors in cortical development. Neuron (2003) 3.21
The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry (2005) 3.05
Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat Cell Biol (2004) 2.75
The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol (2010) 2.64
Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev (2012) 2.54
Central mechanisms of pathological pain. Nat Med (2010) 2.37
Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry (2003) 2.33
Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus (2000) 2.18
Notch in the vertebrate nervous system: an old dog with new tricks. Neuron (2011) 2.14
Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex. Nat Med (2011) 2.11
Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry (2004) 2.11
The cryptochromes. Genome Biol (2005) 2.02
Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J Affect Disord (2009) 1.82
Genetics of bipolar disorder. Lancet (2013) 1.82
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry (2000) 1.71
CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. Mol Cell Biol (2005) 1.64
The connectomics of brain disorders. Nat Rev Neurosci (2015) 1.52
Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology (1992) 1.51
Understanding covalent modifications of proteins by lipids: where cell biology and biophysics mingle. Trends Cell Biol (1997) 1.51
Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol Neurobiol (2003) 1.47
Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus (2011) 1.46
From the neuron doctrine to neural networks. Nat Rev Neurosci (2015) 1.44
The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol (2007) 1.43
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol (2012) 1.40
The power of meta-analysis in genome-wide association studies. Annu Rev Genomics Hum Genet (2013) 1.40
Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry (2006) 1.36
Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol Neurobiol (2011) 1.33
Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase. J Neurochem (1997) 1.33
Photoreceptor-based magnetoreception: optimal design of receptor molecules, cells, and neuronal processing. J R Soc Interface (2010) 1.33
The genetic background to PTSD. Neurosci Biobehav Rev (2006) 1.33
Electrical synapses: a dynamic signaling system that shapes the activity of neuronal networks. Biochim Biophys Acta (2004) 1.31
Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain (2009) 1.29
Evaluating historical candidate genes for schizophrenia. Mol Psychiatry (2015) 1.26
Brain networks in schizophrenia. Neuropsychol Rev (2014) 1.26
A network of genetic repression and derepression specifies projection fates in the developing neocortex. Proc Natl Acad Sci U S A (2012) 1.26
Ventral hippocampal neurons project axons simultaneously to the medial prefrontal cortex and amygdala in the rat. J Neurophysiol (2006) 1.25
Brain imaging of neuropathic pain. Neuroimage (2007) 1.25
Ultrastructure of synapses in the mammalian brain. Cold Spring Harb Perspect Biol (2012) 1.24
Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J Neurochem (2008) 1.21
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res (2009) 1.20
Neurogenesis during development of the vertebrate central nervous system. EMBO Rep (2014) 1.19
AP2gamma regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex. Nat Neurosci (2009) 1.18
Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology (2000) 1.17
Specific and common genes implicated across major mental disorders: a review of meta-analysis studies. J Psychiatr Res (2014) 1.17
Foxg1 haploinsufficiency reduces the population of cortical intermediate progenitor cells: effect of increased p21 expression. Cereb Cortex (2007) 1.16
LMO4 controls the balance between excitatory and inhibitory spinal V2 interneurons. Neuron (2009) 1.16
TMS and drugs revisited 2014. Clin Neurophysiol (2014) 1.15
CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet (2013) 1.14
Molecular control of neurogenesis: a view from the mammalian cerebral cortex. Cold Spring Harb Perspect Biol (2012) 1.13
Proneural genes in neocortical development. Neuroscience (2013) 1.12
16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders. J Hum Genet (2011) 1.12
Illuminating circuitry relevant to psychiatric disorders with optogenetics. Curr Opin Neurobiol (2014) 1.09
Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel. Mol Cell Neurosci (2001) 1.08
Neuronal network plasticity and recovery from depression. JAMA Psychiatry (2013) 1.06
A framework for interpreting functional networks in schizophrenia. Front Hum Neurosci (2012) 1.05
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders. J Neurochem (2013) 1.05
Wiring of the brain by a range of guidance cues. Prog Neurobiol (2002) 1.05
Optogenetics: the age of light. Nat Methods (2014) 1.04
Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia. Biol Psychiatry (2007) 1.03
Activity-dependent neural plasticity from bench to bedside. Neuron (2013) 1.02
Possible Mechanisms Underlying the Therapeutic Effects of Transcranial Magnetic Stimulation. Front Hum Neurosci (2015) 1.01
Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS. Proteomics (2006) 1.00
The molecular epidemiology of pain: a new discipline for drug discovery. Nat Rev Drug Discov (2008) 1.00
Isoform diversity and regulation in peripheral and central neurons revealed through RNA-Seq. PLoS One (2012) 1.00
Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3. Arch Gen Psychiatry (2011) 0.99
Abnormal functional connectivity in posttraumatic stress disorder. Neuroimage (2002) 0.99
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease. Neuroscientist (2014) 0.97
Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2. FEBS Lett (2012) 0.95
Opening Pandora's jar: a primer on the putative roles of CRMP2 in a panoply of neurodegenerative, sensory and motor neuron, and central disorders. Future Neurol (2012) 0.95
Voltage-gated calcium channels and pain. Pain (2006) 0.95
The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res (2014) 0.94
CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB J (2007) 0.94
Transcranial pulsed magnetic field stimulation facilitates reorganization of abnormal neural circuits and corrects behavioral deficits without disrupting normal connectivity. FASEB J (2012) 0.93
The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia. Biol Psychiatry (2003) 0.93
Central pain control. Joint Bone Spine (2006) 0.91
Cell adhesion and homeostatic synaptic plasticity. Neuropharmacology (2013) 0.91
Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol Dis (2013) 0.91
Structural homeostasis in the nervous system: a balancing act for wiring plasticity and stability. Front Cell Neurosci (2015) 0.90
CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus. Dev Neurobiol (2012) 0.90
Voltage-gated calcium channels as targets for the treatment of chronic pain. Curr Drug Targets CNS Neurol Disord (2004) 0.90
CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells. J Neurosci (2011) 0.90
Phenotyping and genotyping neuropathic pain. Curr Pain Headache Rep (2010) 0.89
Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. Hum Mol Genet (2012) 0.89
A preliminary study of alterations in default network connectivity in post-traumatic stress disorder patients following recent trauma. Brain Res (2012) 0.89